(Q45297533)
Statements
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders (English)
Javier Fernández-Ruiz
Ana Cabranes
Gareth Pryce
David Baker
José Antonio Ramos